Department of Chemical Engineering, McGill University, 3610 University Street, Montréal, Québec, Canada H3A 2B2.
Appl Microbiol Biotechnol. 2013 Mar;97(5):2201-10. doi: 10.1007/s00253-012-4054-8. Epub 2012 Apr 26.
The potential development of antibacterial resistance and endocrine disruption has led to increased research investigating the removal of contaminants from wastewater (WW) such as sulfamethoxazole (SMX) and 17α-ethinylestradiol (EE2). These compounds react quickly with ozone (O(3)), thus ozonation during WW treatment may result in their complete removal. Also, O(3) has demonstrated the ability to increase the biodegradability of WW and certain pharmaceuticals, suggesting its potential as a pretreatment to activated sludge (AS, biological treatment). The objective of this study was to determine whether ozonation, conducted at doses lower than commonly applied to treated WW, would lead to an increased biodegradability of SMX and EE2. The results show that after ozonation performed at lab-scale the bacterial mixtures removed 5 % to 40 % more SMX; however, 2 % to 23 % less EE2 was removed, which was attributed to the observed preferential degradation of a by-product of EE2 ozonation. These results suggest that although ozonation, used as a pretreatment, was shown in literature to increase the overall biodegradability of AS as well as some specific antibiotic compounds and a blood lipid regulator, the potential for increased removal of pharmaceuticals seems to be compound-dependent and cannot yet be extrapolated to this entire class of compounds.
从废水中(WW)去除磺胺甲恶唑(SMX)和 17α-乙炔基雌二醇(EE2)等污染物的研究越来越多,这主要是因为其具有抗菌耐药性和内分泌干扰的潜在发展。这些化合物与臭氧(O(3))迅速反应,因此 WW 处理过程中的臭氧氧化可能会导致它们完全去除。此外,O(3)已证明能够提高 WW 和某些药物的生物降解性,这表明其作为活性污泥(AS,生物处理)预处理的潜力。本研究的目的是确定臭氧氧化是否会导致 SMX 和 EE2 的生物降解性增加,其剂量低于通常应用于处理后的 WW。结果表明,在实验室规模下进行臭氧氧化后,细菌混合物去除了 5%至 40%的 SMX;然而,去除的 EE2 减少了 2%至 23%,这归因于观察到 EE2 臭氧氧化的副产物的优先降解。这些结果表明,尽管臭氧氧化作为预处理在文献中显示可提高 AS 的整体生物降解性以及一些特定抗生素化合物和血液脂质调节剂的生物降解性,但增加药物去除的潜力似乎取决于化合物,并且不能推断为整个类别的化合物。